Skip to main content

Table 3 Incidences of gastrointestinal and genitourinary acute and late toxicities (n = 261)

From: Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer: clinical outcomes

Grade GI toxicity n (%) GU toxicity n (%)
  Acute Late Acute Late
1 64 (24.5) 26 (10.0) 148 (56.7) 37 (14.1)
2 6 (2.3) 5 (1.9) 50 (19.2) 27 (10.3)
3 0 1 (0.4) 0 3 (1.1)
  1. GI gastrointestinal, GU genitourinary